The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Open accessAbstract
It is estimated that 30% of the adult population in Japan is affected by nonalcoholic fatty liver disease (NAFLD). Fatty changes of the liver are generally diagnosed using imaging methods such as abdominal ultrasonography (US) and computed tomography (CT), but the sensitivity of these imaging techniques is low in cases of mild steatosis. Alanine aminotransferase levels may be normal in some of these patients, warranting the necessity to establish a set of parameters useful for detecting NAFLD, and the more severe form of the disease, nonalcoholic steatohepatitis (NASH). Although liver biopsy is currently the gold standard for diagnosing progressive NASH, it has many drawbacks, such as sampling error, cost, and risk of complications. Furthermore, it is not realistic to perform liver biopsies on all NAFLD patients. Diagnosis of NASH using various biomarkers, scoring systems and imaging methods, such as elastography, has recently been attempted. The NAFIC score, calculated from the levels of ferritin, fasting insulin, and type IV collagen 7S, is useful for the diagnosis of NASH, while the NAFLD fibrosis score and the FIB-4 index are useful for excluding NASH in cases of advanced fibrosis. This article reviews the limitations and merits of liver biopsy and noninvasive diagnostic tests in the diagnosis of NAFLD/NASH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,203
Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., & Tiribelli, C. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-33 · Cited by 3,042
The utility of radiological imaging in nonalcoholic fatty liver disease
Saadeh, S., Younossi, Z. M., Remer, E. M., Gramlich, T., Ong, J. P., Hurley, M., Mullen, K. D., Cooper, J. N., & Sheridan, M. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35354 · Cited by 2,110
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
Ratziu, V., Charlotte, F., Heurtier, A., Gombert, S., Giral, P., Bruckert, E., Grimaldi, A., Capron, F., & Poynard, T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.084 · Cited by 2,106
Rockey, D. C., Caldwell, S. H., Goodman, Z. D., Nelson, R. C., & Smith, A. D. (2009) · Hepatology · doi:10.1002/hep.22742 · Cited by 1,997
Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
Lee, J.-H., Kim, D., Kim, H. J., Lee, C.-H., Yang, J. I., Kim, W., Kim, Y. J., Yoon, J.-H., Cho, S.-H., Sung, M.-W., et al. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.08.002 · Cited by 1,621
Hernaez, R., Lazo, M., Bonekamp, S., Kamel, I., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · Hepatology · doi:10.1002/hep.24452 · Cited by 1,585
Szczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H., & Dobbins, R. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562
Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Shah, A. G., Lydecker, A., Murray, K., Tetri, B. N., Contos, M. J., & Sanyal, A. J. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.05.033 · Cited by 1,553
Dixon, J. B., Bhathal, P. S., & O'Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,360
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,293
Brunt, E. M., Kleiner, D. E., Wilson, L. A., Belt, P., & Neuschwander-Tetri, B. A. (2011) · Hepatology · doi:10.1002/hep.24127 · Cited by 1,251
Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey
Cadranel, J.-F., Rufat, P., & Degos, F. (2000) · Hepatology · doi:10.1053/jhep.2000.16602 · Cited by 993
Speliotes, E. K., Yerges-Armstrong, L. M., Wu, J., Hernaez, R., Kim, L. J., Palmer, C. D., Gudnason, V., Eiriksdottir, G., Garcia, M. E., Launer, L. J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001324 · Cited by 984
Sookoian, S., & Pirola, C. J. (2011) · Hepatology · doi:10.1002/hep.24283 · Cited by 920
Harrison, S. A., Oliver, D., Arnold, H. L., Gogia, S., & Neuschwander-Tetri, B. A. (2008) · Gut · doi:10.1136/gut.2007.146019 · Cited by 869
Kim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology · doi:10.1002/hep.26156 · Cited by 772
Endpoints and clinical trial design for nonalcoholic steatohepatitis
Sanyal, A. J., Brunt, E. M., Kleiner, D. E., Kowdley, K. V., Chalasani, N., Lavine, J. E., Ratziu, V., & McCullough, A. (2011) · Hepatology · doi:10.1002/hep.24376 · Cited by 750
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
Rafiq, N., Bai, C., Fang, Y., Srishord, M., McCullough, A., Gramlich, T., & Younossi, Z. M. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.11.005 · Cited by 729
Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study
Dasarathy, S., Dasarathy, J., Khiyami, A., Joseph, R., Lopez, R., & McCullough, A. J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.09.001 · Cited by 656
Younossi, Z. M., Stepanova, M., Rafiq, N., Makhlouf, H., Younoszai, Z., Agrawal, R., & Goodman, Z. (2011) · Hepatology · doi:10.1002/hep.24268 · Cited by 638
JSG-NAFLD, Eguchi, Y., Hyogo, H., Ono, M., Mizuta, T., Ono, N., Fujimoto, K., Chayama, K., & Saibara, T. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0533-z · Cited by 551
Rotman, Y., Koh, C., Zmuda, J. M., Kleiner, D. E., & Liang, J. T. (2010) · Hepatology · doi:10.1002/hep.23759 · Cited by 475
Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease
Petersen, K. F., Dufour, S., Hariri, A., Nelson-Williams, C., Foo, J. N., Zhang, X.-M., Dziura, J., Lifton, R. P., & Shulman, G. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907295 · Cited by 428
Yoneda, M., Yoneda, M., Mawatari, H., Fujita, K., Endo, H., Iida, H., Nozaki, Y., Yonemitsu, K., Higurashi, T., Takahashi, H., et al. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.10.019 · Cited by 428
Noninvasive assessment of liver fibrosis
Martínez, S. M., Crespo, G., Navasa, M., & Forns, X. (2011) · Hepatology · doi:10.1002/hep.24013 · Cited by 422
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population
Sumida, Y., Yoneda, M., Hyogo, H., Itoh, Y., Ono, M., Fujii, H., Eguchi, Y., Suzuki, Y., Aoki, N., Kanemasa, K., et al. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-2 · Cited by 383
Self-citationThe diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis
Poynard, T., Ratziu, V., Naveau, S., Thabut, D., Charlotte, F., Messous, D., Capron, D., Abella, A., Massard, J., Ngo, Y., et al. (2005) · Comparative Hepatology · doi:10.1186/1476-5926-4-10 · Cited by 368
de Lédinghen, V., Vergniol, J., Foucher, J., Merrouche, W., & le Bail, B. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02820.x · Cited by 367
Daniel, S. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00507-9 · Cited by 354
Merriman, R. B., Ferrell, L. D., Patti, M. G., Weston, S. R., Pabst, M. S., Aouizerat, B. E., & Bass, N. M. (2006) · Hepatology · doi:10.1002/hep.21346 · Cited by 324
Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.
Younossi, Z. M., Gramlich, T., Liu, Y. C., Matteoni, C. A., Petrelli, M., Goldblum, J. R., Rybicki, L. A., & McCullough, A. J. (1998) · PubMed · Cited by 321
Skelly, M. M., James, P. D., & Ryder, S. D. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00094-0 · Cited by 310
the LIDO Study Group and the CYTOL study group, Poynard, T., Ratziu, V., Charlotte, F., Messous, D., Munteanu, M., Imbert-Bismut, F., Massard, J., Bonyhay, L., Tahiri, M., et al. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-34 · Cited by 302
Nonalcoholic Fatty Liver Disease in Severely Obese Subjects
Gholam, P. M., Flancbaum, L., Machan, J. T., Charney, D. A., & Kotler, D. P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.01041.x · Cited by 296
Kawamura, Y., Arase, Y., Ikeda, K., Seko, Y., Imai, N., Hosaka, T., Kobayashi, M., Saitoh, S., Sezaki, H., Akuta, N., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.327 · Cited by 280
Kawaguchi, T., Sumida, Y., Umemura, A., Matsuo, K., Takahashi, M., Takamura, T., Yasui, K., Saibara, T., Hashimoto, E., Kawanaka, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038322 · Cited by 264
Self-citationFatty liver index and mortality: The cremona study in the 15th year of follow-up
Calori, G., Lattuada, G., Ragogna, F., Garancini, M. P., Crosignani, P., Villa, M., Bosi, E., Ruotolo, G., Piemonti, L., & Perseghin, G. (2011) · Hepatology · doi:10.1002/hep.24356 · Cited by 253
&NA; (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200111000-00029 · Cited by 243
Noninvasive Evaluation of Graft Steatosis in Living Donor Liver Transplantation
Iwasaki, M., Takada, Y., Hayashi, M., Minamiguchi, S., Haga, H., Maetani, Y., Fujii, K., Kiuchi, T., & Tanaka, K. (2004) · Transplantation · doi:10.1097/01.tp.0000140499.23683.0d · Cited by 230
Palekar, N. A., Naus, R., Larson, S. P., Ward, J., & Harrison, S. A. (2006) · Liver International · doi:10.1111/j.1478-3231.2005.01209.x · Cited by 216
Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD), Sumida, Y., Yoneda, M., Hyogo, H., Yamaguchi, K., Ono, M., Fujii, H., Eguchi, Y., Suzuki, Y., Imai, S., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-010-0305-6 · Cited by 199
Self-citationVuppalanchi, R., Ünalp, A., Van Natta, M. L., Cummings, O. W., Sandrasegaran, K. E., Hameed, T., Tonascia, J., & Chalasani, N. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.12.015 · Cited by 198
Magnetic resonance imaging and spectroscopy for monitoring liver steatosis
Cowin, G. J., Jonsson, J. R., Bauer, J. D., Ash, S., Ali, A., Osland, E. J., Purdie, D. M., Clouston, A. D., Powell, E. E., & Galloway, G. J. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21542 · Cited by 191
Hotta, K., Yoneda, M., Hyogo, H., Ochi, H., Mizusawa, S., Ueno, T., Chayama, K., Nakajima, A., Nakao, K., & Sekine, A. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-172 · Cited by 174
A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients
Campos, G. M., Bambha, K., Vittinghoff, E., Rabl, C., Posselt, A. M., Ciovica, R., Tiwari, U., Ferrel, L., Pabst, M., Bass, N. M., et al. (2008) · Hepatology · doi:10.1002/hep.22241 · Cited by 172
Anty, R., Iannelli, A., Patouraux, S., Bonnafous, S., Lavallard, V., Buratti, M. S., Amor, I. B., Staccini-Myx, A., Saint‐Paul, M., Berthier, F., et al. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04480.x · Cited by 171
Juluri, R., Vuppalanchi, R., Olson, J. D., Ünalp, A., Natta, M. L. V., Cummings, O. W., Tonascia, J. A., & Chalasani, N. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181dd1348 · Cited by 166
Shimada, M., Kawahara, H., Ozaki, K., Fukura, M., Yano, H., Tsuchishima, M., Tsutsumi, M., & Takase, S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01322.x · Cited by 163
Machann, J., Thamer, C., Schnoedt, B., Stefan, N., Haring, H., Claussen, C. D., Fritsche, A., & Schick, F. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20825 · Cited by 162
Hernáez, R., McLean, J., Lazo, M., Brancati, F. L., Hirschhorn, J. N., Borecki, I. B., Harris, T. B., Nguyen, T. T., Kamel, I. R., Bonekamp, S., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.011 · Cited by 149
Platelet count for predicting fibrosis in nonalcoholic fatty liver disease
Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD), Yoneda, M., Fujii, H., Sumida, Y., Hyogo, H., Itoh, Y., Ono, M., Eguchi, Y., Suzuki, Y., Aoki, N., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0436-4 · Cited by 143
Self-citationWong, V. W., Wong, G. L., Chim, A. M., Tse, A. M. L., Tsang, S. W., Hui, A., Choi, P. C., Chan, A. W. H., So, W., Chan, F. K. L., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01933.x · Cited by 126
Histologic Variation of Grade and Stage of Non-alcoholic Fatty Liver Disease in Liver Biopsies
Janiec, D. J., Jacobson, E. R., Freeth, A., Spaulding, L., & Blaszyk, H. (2005) · Obesity Surgery · doi:10.1381/0960892053723268 · Cited by 119
Larson, S. P., Bowers, S. P., Palekar, N. A., Ward, J. A., Pulcini, J. P., & Harrison, S. A. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.06.005 · Cited by 113
Imaging techniques for assessing hepatic fat content in nonalcoholic fatty liver disease
Roldán-Valadéz, E., Favila, R., Martínez-López, M., Uribe, M., & Méndez‐Sánchez, N. (2008) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31850-2 · Cited by 113
Goldstein, N. S., Hastah, F., Galan, M. V., & Gordon, S. C. (2005) · American Journal of Clinical Pathology · doi:10.1309/ey72f1en9xcb1kxx · Cited by 113
McPherson, S., Anstee, Q. M., Henderson, E., Day, C. P., & Burt, A. D. (2013) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32835d72cf · Cited by 108
Gawrieh, S., Knoedler, D. M., Saeian, K., Wallace, J. R., & KOMOROWSKI, R. A. (2010) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2010.08.001 · Cited by 107
Controversies in liver biopsy: Who, where, when, how, why?
Friedman, L. S. (2004) · Current Gastroenterology Reports · doi:10.1007/s11894-004-0023-4 · Cited by 106
Twenty‐year audit of percutaneous liver biopsy in a major Australian teaching hospital
van der Poorten, D., Kwok, A., Lam, T., Ridley, L. J., Jones, D. B., Ngu, M. C., & Lee, A. U. (2006) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2006.01216.x · Cited by 101
Decrease in accumulation of ultrasound contrast microbubbles in non‐alcoholic steatohepatitis
Iijima, H., Moriyasu, F., Tsuchiya, K., Suzuki, S., Yoshida, M., Shimizu, M., Sasaki, S., Nishiguchi, S., & Maeyama, S. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00130.x · Cited by 99
Gorden, A., Yang, R., Yerges‐Armstrong, L. M., Ryan, K. A., Speliotes, E. K., Borecki, I. B., Harris, T. B., Chu, X., Wood, G. C., Still, C. D., et al. (2013) · Human Heredity · doi:10.1159/000346195 · Cited by 97
Validation of the non-alcoholic fatty liver disease activity score
Hjelkrem, M., Stauch, C., Shaw, J., & Harrison, S. A. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04695.x · Cited by 82
Can Nash Be Diagnosed, Graded, and Staged Noninvasively?
Grandison, G. A., & Angulo, P. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.05.001 · Cited by 75
Nonalcoholic Fatty Liver Disease: A Practical Approach to Evaluation and Management
Rafiq, N., & Younossi, Z. M. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.02.009 · Cited by 72
Serum cytokeratin‐18 in the diagnosis of non‐alcoholic steatohepatitis: A meta‐analysis
Chen, J., Zhu, Y., Zheng, Q., & Jiang, J. (2013) · Hepatology Research · doi:10.1111/hepr.12197 · Cited by 53
Applicability of BARD score to Japanese patients with NAFLD
Fujii, H., Enomoto, M., Fukushima, W., Tamori, A., Sakaguchi, H., & Kawada, N. (2009) · Gut · doi:10.1136/gut.2009.182758 · Cited by 45
&NA; (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200108000-00028 · Cited by 42
Motion – All Patients with NASH Need to Have a Liver Biopsy: Arguments against the Motion
Laurin, J. M. (2002) · Canadian Journal of Gastroenterology · doi:10.1155/2002/614302 · Cited by 27
Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan
Sumida, Y., Eguchi, Y., & Ono, M. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i10.374 · Cited by 16
Self-citationYilmaz, Y. N. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.09.002 · Cited by 9
Cited by
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Aron-Wisnewsky, J., Vigliotti, C., Witjes, J., Le, P., Holleboom, A. G., Verheij, J., Nieuwdorp, M., & Clément, K. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0269-9 · Cited by 1,063
Aptamer-Based Detection of Circulating Targets for Precision Medicine
Wu, L., Wang, Y., Xu, X., Liu, Y., Lin, B., Zhang, M., Zhang, J., Wan, S., Yang, C., & Tan, W. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01140 · Cited by 705
NAFLD as a Continuum: From Obesity to Metabolic Syndrome and Diabetes
Godoy-Matos, A. F., Silva Júnior, W. S., & Valerio, C. M. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00570-y · Cited by 643
Hsu, C., Caussy, C., Imajo, K., Chen, J., Singh, S., Kaulback, K., Le, M.-D., Hooker, J., Tu, X., Bettencourt, R., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.05.059 · Cited by 415
Metadata
- Authors
- Sumida, Y.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2014
- Volume
- 20
- Issue
- 2
- Pages
- 475
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2000641576
- Cited by
- 689
- References
- 77
- FWCI
- 22.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.